A key barrier to effective PD treatment is the slow, inconsistent patient recruitment process for clinical trials, especially ...

The global non-invasive brain stimulation systems market is on a trajectory of significant expansion, according to a recent report by Future Market Insight. The market, valued at USD 1,200.5 million ...

Parkinson’s disease disrupts lives by slowly robbing people of their ability to move, speak, and function with ease. It's the ...

Robeauté’s microrobot, which is the size of a grain of rice, could change the way doctors treat brain tumors and neurological ...

Normal pressure hydrocephalus, a condition in which cerebrospinal fluid builds up in the brain, can lead to issues such as ...

These studies showed AAV-GAD’s potential benefits when administered as a one-time treatment for Parkinson’s disease ... through a minimally invasive procedure. The therapy aims to restore ...

These studies showed AAV-GAD’s potential benefits when administered as a one-time treatment for Parkinson’s disease patients whose ... through a minimally invasive procedure. The therapy aims to ...

This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson's disease - RMAT designation includes the benefits ...

(MENAFN- GlobeNewsWire - Nasdaq) - This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson's disease ...